Recent approvals and ongoing research have expanded the number of treatment options available to pediatricians and their patients.
Julian Kaye, PhD
Advertisement
Articles by Julian Kaye, PhD
Advertisement
Latest Updated Articles
Update in Biologic Medications for Pediatric Rheumatic DiseaseOctober 16th 2014
Advertisement
Advertisement
Trending on Rheumatology Live
1
Nipocalimab, Telitacicept, and the Sjögren’s Disease Pipeline
2
Dazodalibep Eases Sjögren’s Dryness via CD40L Blockade: Ghaith Noaiseh, MD
3
Dazodalibep Lowers Sjögren’s Disease Activity: Ghaith Noaiseh, MD
4
Selecting Sjögren’s Patients for Ianalumab and Weighing Safety
5